Journal of Acupuncture Research

  • 제40권1호
  • /
  • Pages.53-60
  • /
  • 2023
  • /
  • 2586-288X(pISSN)
  • /
  • 2586-2898(eISSN)
대한침구의학회 (Korean Acupuncture & Moxibustion Medicine Society)
권호 표지
DOI QR코드

DOI QR Code

Anti-Hyperuricemic Effects of Oenanthe javanica Extracts in Hyperuricemia-Induced Rats

  • Woo-Ju, Lee (Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Gachon University) ;
  • Ho-Sueb, Song (Department of Acupuncture & Moxibustion Medicine, College of Korean Medicine, Gachon University)
  • 투고 : 2022.01.05
  • 심사 : 2022.01.16
  • 발행 : 2023.02.28
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: This study aimed to investigate the effects of Oenanthe javanica (OJ) extracts on rats with potassium oxonate (PO)-induced hyperuricemia. Methods: The effects of OJ extract on rats with PO-induced hyperuricemia-induced were monitored. Changes in the body weight and organ indices of hyperuricemic rats were calculated to detect anti-hyperuricemic effects. Blood samples were collected to observe the effect of reducing serum uric acid concentration. Kidney tissues were stained to observe histopathological changes under a microscope. The activity of xanthine oxidase (XO), which catalyzes xanthine to uric acid in the liver, was assessed to observe the inhibitory effect of XO. Results: 1. The body weight of hyperuricemic rats showed no considerable differences between the control group and the treatment group. The OJ group had significantly improved liver index, whereas the allopurinol group had improved liver and kidney indices. 2. Serum uric acid levels increased significantly after PO injection, and the OJ and allopurinol groups showed a significant reduction effect. 3. PO injection led to the inflammation of kidney tissues, and OJ improved it significantly. 4. The activity of XO after PO injection was significantly increased, and allopurinol significantly inhibited XO activity in the liver. Conclusion: In the hyperuricemia rat model, OJ extract reduced uric acid concentration and demonstrated its anti-inflammatory effects. Thus, OJ extracts can be used to lower uric acid levels.

키워드

참고문헌

  1. Dalbeth N, Gosling AL, Gaffo A, Abhishek A. Gout. Lancet 2021;397:1843-1855. doi: 10.1016/S0140-6736(21)00569-9 Erratum in: Lancet 2021;397:1808.
  2. Taylor WJ, Fransen J, Jansen TL, Dalbeth N, Schumacher HR, Brown M, et al. Study for updated gout classification criteria: identification of features to classify gout. Arthritis Care Res (Hoboken) 2015;67:1304-1315. doi: 10.1002/acr.22585
  3. Kim Y, Kang J, Kim GT. Prevalence of hyperuricemia and its associated factors in the general Korean population: an analysis of a population-based nationally representative sample. Clin Rheumatol 2018;37:2529-2538. doi: 10.1007/s10067-018-4130-2
  4. Malik A, Schumacher HR, Dinnella JE, Clayburne GM. Clinical diagnostic criteria for gout: comparison with the gold standard of synovial fluid crystal analysis. J Clin Rheumatol 2009;15:22-24. doi: 10.1097/RHU.0b013e3181945b79
  5. Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, et al. 2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2015;74:1789-1798. doi:10.1136/annrheumdis-2015-208237 Erratum in: Ann Rheum Dis 2016;75:473.
  6. Huo S, Wang H, Yan M, Xu P, Song T, Li C, et al. Urinary proteomic characteristics of hyperuricemia and their possible links with the occurrence of its concomitant diseases. ACS Omega 2021;6:9500-9508. doi: 10.1021/acsomega.0c06229
  7. Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med 1987;82:421-426. doi: 10.1016/0002-9343(87)90441-4
  8. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 2011;63:3136-3141. doi: 10.1002/art.30520
  9. Maiuolo J, Oppedisano F, Gratteri S, Muscoli C, Mollace V. Regulation of uric acid metabolism and excretion. Int J Cardiol 2016;213:8-14. doi: 10.1016/j.ijcard.2015.08.109
  10. Choi HK, Ford ES, Li C, Curhan G. Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2007;57:109-115. doi: 10.1002/art.22466
  11. FitzGerald JD, Dalbeth N, Mikuls T, Brignardello-Petersen R, Guyatt G, Abeles AM, et al. 2020 American College of Rheumatology Guideline for the management of gout. Arthritis Care Res (Hoboken) 2020;72:744-760. doi: 10.1002/acr.24180 Erratum in: Arthritis Care Res (Hoboken) 2020;72:1187. Erratum in: Arthritis Care Res (Hoboken) 2021;73:458.
  12. Stamp LK, Taylor WJ, Jones PB, Dockerty JL, Drake J, Frampton C, et al. Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol. Arthritis Rheum 2012;64:2529-2536. doi: 10.1002/art.34488
  13. He S, Tang M, Zhang Z, Liu H, Luo M, Sun H. Hypoglycemic effects of phenolic compound-rich aqueous extract from water dropwort (Oenanthe javanica DC.) on streptozotocin-induced diabetic mice. New J Chem 2020;44:5190-5200. doi: 10.1039/C9NJ05533A
  14. Lee DH, Lee JS, Lee IH, Hong JT. Therapeutic potency of fermented field water-dropwort (Oenanthe javanica (Blume) DC.) in ethanol-induced liver injury. RSC Adv 2020;10:1544-1551. doi:10.1039/c9ra08976d
  15. Lu CL, Li XF. A review of Oenanthe javanica (Blume) DC. as traditional medicinal plant and its therapeutic potential. Evid Based Complement Alternat Med 2019;2019:6495819. doi: 10.1155/2019/6495819
  16. Park W. Recent progress in the management of gouty arthritis and hyperuricemia. Korean J Med 2011;80:260-268.
  17. Kim JW, Kwak SG, Lee H, Kim SK, Choe JY, Park SH. Prevalence and incidence of gout in Korea: data from the national health claims database 2007-2015. Rheumatol Int 2017;37:1499-1506. doi: 10.1007/s00296-017-3768-4
  18. Johnson RJ, Bakris GL, Borghi C, Chonchol MB, Feldman D, Lanaspa MA, et al. Hyperuricemia, acute and chronic kidney disease, hypertension, and cardiovascular disease: report of a scientific workshop organized by the National Kidney Foundation. Am J Kidney Dis 2018;71:851-865. doi: 10.1053/j.ajkd.2017.12.009
  19. Qaseem A, Harris RP, Forciea MA; Clinical Guidelines Committee of the American College of Physicians, Denberg TD, Barry MJ, et al. Management of acute and recurrent gout: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2017;166:58-68. doi: 10.7326/M16-0570
  20. Stamp LK, Day RO, Yun J. Allopurinol hypersensitivity: investigating the cause and minimizing the risk. Nat Rev Rheumatol 2016;12:235-242. doi: 10.1038/nrrheum.2015.132 Erratum in: Nat Rev Rheumatol 2016;12:i.
  21. Jutkowitz E, Dubreuil M, Lu N, Kuntz KM, Choi HK. The cost-effectiveness of HLA-B*5801 screening to guide initial urate-lowering therapy for gout in the United States. Semin Arthritis Rheum 2017;46:594-600. doi: 10.1016/j.semarthrit.2016.10.009
  22. Singh JA, Richman J, Yang S, Bridges SL, Saag K. Allopurinol adherence and its predictors in gout: a national cohort study in US veterans. Lancet Rheumatol 2020;2:e281-e291. doi: 10.1016/S2665-9913(20)30029-1
  23. Braga TT, Forni MF, Correa-Costa M, Ramos RN, Barbuto JA, Branco P, et al. Soluble uric acid activates the NLRP3 inflammasome. Sci Rep 2017;7:39884. doi: 10.1038/srep39884
  24. Patil T, Soni A, Acharya S. A brief review on in vivo models for Gouty Arthritis. Metabol Open 2021;11:100100. doi: 10.1016/j.metop.2021.100100
  25. Chaudhary K, Malhotra K, Sowers J, Aroor A. Uric acid - key ingredient in the recipe for cardiorenal metabolic syndrome. Cardiorenal Med 2013;3:208-220. doi: 10.1159/000355405
  26. Lee YS, Sung YY, Yuk HJ, Son E, Lee S, Kim JS, et al. Anti-hyperuricemic effect of Alpinia oxyphylla seed extract by enhancing uric acid excretion in the kidney. Phytomedicine 2019;62: 152975. doi: 10.1016/j.phymed.2019.152975
  27. Park JE, Yeom Z, Park KT, Han EH, Yu HJ, Kang HS, et al. Hypouricemic effect of ethanol extract of Aster glehni leaves in potassium oxonate-induced hyperuricemic rats. Clin Nutr Res 2018;7:126-135. doi: 10.7762/cnr.2018.7.2.126
  28. Hongyan L, Suling W, Weina Z, Yajie Z, Jie R. Antihyperuricemic effect of liquiritigenin in potassium oxonate-induced hyperuricemic rats. Biomed Pharmacother 2016;84:1930-1936. doi: 10.1016/j.biopha.2016.11.009
  29. Ma QG, Wei RR, Sang ZP. Biphenyl derivatives from the aerial parts of Oenanthe javanica and their COX-2 inhibitory activities. Chem Biodivers 2019;16:e1800480. doi: 10.1002/cbdv.201800480
  30. Wei RR, Ma QG. Flavonolignan 2, 3-dehydroderivatives from Oenanthe javanica and their anti inflammatory activities. Z Naturforsch C J Biosci 2021;76:459-465. doi: 10.1515/znc-2021-0001
  31. Liu J, Chang Y, Sun L, Du F, Cui J, Liu X, et al. Abundant allelochemicals and the inhibitory mechanism of the phenolic acids in water dropwort for the control of Microcystis aeruginosa blooms. Plants (Basel) 2021;10:2653. doi: 10.3390/plants10122653
  32. Ai G, Huang ZM, Liu QC, Han YQ, Chen X. The protective effect of total phenolics from Oenanthe Javanica on acute liver failure induced by D-galactosamine. J Ethnopharmacol 2016;186:53-60. doi: 10.1016/j.jep.2016.03.024
  33. Ahn H, Lee GS. Isorhamnetin and hyperoside derived from water dropwort inhibits inflammasome activation. Phytomedicine 2017;24:77-86. doi: 10.1016/j.phymed.2016.11.019
  34. Jo BR, Kim HS, Ahn JW, Jeoung EY, Jang SK, Yoo YM, et al. A novel antiviral protein derived from Oenanthe javanica: type I interferon-dependent antiviral signaling and its pharmacological potential. Biomolecules 2022;12:835. doi: 10.3390/biom12060835
  35. Tang DH, Ye YS, Wang CY, Li ZL, Zheng H, Ma KL. Potassium oxonate induces acute hyperuricemia in the tree shrew (tupaia belangeri chinensis). Exp Anim 2017;66:209-216. doi: 10.1538/expanim.16-0096
  36. Feng Y, Sun F, Gao Y, Yang J, Wu G, Lin S, et al. Taurine decreased uric acid levels in hyperuricemic rats and alleviated kidney injury. Biochem Biophys Res Commun 2017;489:312-318. doi: 10.1016/j.bbrc.2017.05.139
  37. Jin R, Gu HY, Li LL, Sun LL. [Current status of Chinese herbal preparations included in LiverTox database]. Zhonghua Gan Zang Bing Za Zhi 2016;24:817-823. Chinese. doi: 10.3760/cma.j.issn.1007-3418.2016.11.005
  38. Lusco MA, Fogo AB, Najafian B, Alpers CE. AJKD atlas of renal pathology: gouty nephropathy. Am J Kidney Dis 2017;69:e5-e6. doi: 10.1053/j.ajkd.2016.11.006
  39. Isaka Y, Takabatake Y, Takahashi A, Saitoh T, Yoshimori T. Hyperuricemia-induced inflammasome and kidney diseases. Nephrol Dial Transplant 2016;31:890-896. doi: 10.1093/ndt/gfv024
  40. Mehmood A, Zhao L, Ishaq M, Usman M, Zad OD, Hossain I, et al. Uricostatic and uricosuric effect of grapefruit juice in potassium oxonate-induced hyperuricemic mice. J Food Biochem 2020;44:e13213. doi: 10.1111/jfbc.13213
  41. Becker MA, Schumacher HR Jr, Wortmann RL, MacDonald PA, Eustace D, Palo WA, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 2005;353:2450-2461. doi: 10.1056/NEJMoa050373